News for Kodiak Sciences Inc. (KOD.MX)

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 100 points on Tuesday. Shares of Polaris Inc. PII fell sharply in today's pre...

One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.

PR NewswirePALO ALTO, Calif., Jan. 7, 2025 PALO ALTO, Calif., Jan. 7, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 300 points on Thursday. The Dow traded down 0.79% to 42,208.88 while ...

Shares of Rumble Inc.

CAMBRIDGE, Mass., Dec. 10, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to ITM), ranging from target validation and antibody discovery through preclinical research, today announced a collaboration with Kodiak Sciences Inc. (Nasdaq: KOD). This partnership aims to advance the discovery of novel multi-target antibodies to treat ophthalmic diseases, leveraging Nona's proprietary Harbour Mice® fully human antibody platform.

U.S. stocks were lower, with the Nasdaq Composite falling around 100 points on Monday. Shares of Pactiv Evergreen Inc. PTVE rose sharply during Monday's sessio...

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

Kodiak Sciences to Present at Innovate Retina 2024

Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow t...

The increasing number of diagnosed cases of wet AMD, the current therapies, and the launch of emerging therapies will drive the wet AMD market growth in...

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.00 A.M. ET)..

Bruce & Co. BRUFX portfolio, holdings, 13f and stock news. Updated: 2023-02-15 portfolio, holdings, 13F and news. Updated: 2023-02-15

Read Comparing Kodiak Sciences (NASDAQ:KOD) and CytRx (OTCMKTS:CYTR) at ETF Daily News

DelveInsight’s Wet AMD pipeline analysis depicts a robust space with 70+ active players working to develop 80+ pipeline therapies....

/PRNewswire/ -- DelveInsight's Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment practices,...